A TonB dependent transporter YncD of Salmonella enterica Serovar Typhi possesses vaccine potential
- PMID: 38470539
- DOI: 10.1007/s11274-024-03937-9
A TonB dependent transporter YncD of Salmonella enterica Serovar Typhi possesses vaccine potential
Abstract
Multiple TonB dependent transporters (TBDTs) contribute to bacterial virulence due to the importance roles that their substrates play in bacterial growth, and possess vaccine potential. A putative TBDT, YncD, had been identified as one of in vivo induced antigens during human infection of typhoid fever, and is required for the pathogenicity of Salmonella enterica Serovar Typhi. The present study was aimed to determine the function and immunogenicity of YncD. Homologous recombination method was used to construct an yncD-deletion mutant and cirA-iroN-fepA-deletion mutant from the wild-type S. Typhi Ty2. The growth of mutants and the wild-type strain were assessed in iron-deficient medium, as well as in human macrophage cells. Recombinant YncD protein was expressed and purified using Ni-NTA affinity chromatography and anion exchange. A mouse model was then used to evaluate the immunogenicity and protection efficacy of the recombinant YncD. Antibody levels, serum bactericidal efficiency, passive immune protection, opsonophagocysis were assayed to analyse the immunoprotection mechanism of the recombinant YncD. Our results showed that YncD is associated with the iron-uptake of S. Typhi. The yncD-deletion mutant displayed impaired growth in iron-deficient medium, comparable to that the cirA-iroN-fepA-deletion mutant did. The mutation of yncD markedly decreased bacterial growth within human macrophage cells. Moreover, subcutaneous immunization of mice with recombinant YncD elicited high levels of specific anti-YncD IgG, IgG1 and IgG2a, which protected the immunized mice against the intraperitoneal challenge of S. Typhi, and decreased bacterial burdens in the livers and spleens of the infected mice. Passive immunization using the immunized sera also efficiently protected the mice from the challenge of S. Typhi. Moreover, the immunized sera enhanced in vitro bactericidal activity of complement, and opsonophagocytosis. Our results showed that YncD displays a role in the iron-uptake of S. Typhi and possesses immunogenicity.
Keywords: Salmonella enterica Serovar Typhi; Immunogenicity; Pathogenicity; TonB dependent transporter; Vaccine.
© 2024. The Author(s), under exclusive licence to Springer Nature B.V.
Similar articles
-
Deletion of yncD gene in Salmonella enterica ssp. enterica serovar Typhi leads to attenuation in mouse model.FEMS Microbiol Lett. 2012 Mar;328(1):70-7. doi: 10.1111/j.1574-6968.2011.02481.x. Epub 2012 Jan 10. FEMS Microbiol Lett. 2012. PMID: 22150228
-
Safety and immunogenicity of an attenuated Salmonella enterica serovar Paratyphi A vaccine candidate.Int J Med Microbiol. 2015 Sep;305(6):563-71. doi: 10.1016/j.ijmm.2015.07.004. Epub 2015 Jul 26. Int J Med Microbiol. 2015. PMID: 26239100
-
Construction of an attenuated Salmonella enterica serovar Paratyphi A vaccine strain harboring defined mutations in htrA and yncD.Microbiol Immunol. 2015 Aug;59(8):443-51. doi: 10.1111/1348-0421.12276. Microbiol Immunol. 2015. PMID: 26084199
-
Vi Capsular Polysaccharide Produced by Recombinant Salmonella enterica Serovar Paratyphi A Confers Immunoprotection against Infection by Salmonella enterica Serovar Typhi.Front Cell Infect Microbiol. 2017 Apr 24;7:135. doi: 10.3389/fcimb.2017.00135. eCollection 2017. Front Cell Infect Microbiol. 2017. PMID: 28484685 Free PMC article.
-
M-01ZH09, an oral live attenuated Salmonella enterica serovar Typhi vaccine for the prevention of typhoid fever.Curr Opin Mol Ther. 2009 Oct;11(5):565-71. Curr Opin Mol Ther. 2009. PMID: 19806505 Review.
Cited by
-
Virulence factors of Salmonella Typhi: interplay between the bacteria and host macrophages.Arch Microbiol. 2025 Mar 17;207(4):89. doi: 10.1007/s00203-025-04297-0. Arch Microbiol. 2025. PMID: 40095029 Review.
-
High-affinity PQQ import is widespread in Gram-negative bacteria.Sci Adv. 2025 May 30;11(22):eadr2753. doi: 10.1126/sciadv.adr2753. Epub 2025 May 30. Sci Adv. 2025. PMID: 40446051 Free PMC article.
References
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical